학술논문
Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1 –S Cell-Cycle Transition
Document Type
Article
Author
Source
In: Cancer Research Communications . (Cancer Research Communications, March 2022, 2(3):131-145)
Subject
Language
English
ISSN
27679764